Under the terms of the agreement, TriLink is providing Applied Biosystems with custom dye-labeled oligonucleotides, or chemically synthesized nucleotides, which are used as part of the DNA sequencing process.
Kim Caple, vice president and general manager for Applied Biosystems’ next-generation sequencing business, said: “Working with best-in-class suppliers like TriLink has enabled us to develop the most robust, accurate, and highest-throughput genetic analysis platform available to help our customers take advantage of the emerging applications for next-generation DNA sequencing.”
Dr. Richard Hogrefe, CEO of TriLink, said: “We are proud that Applied Biosystems has chosen TriLink to be the supplier of the oligonucleotides used in the SOLiD system.”